BUZZ-Alimera Sciences Inc: FDA approves eye implant
** Drug developer's shares up 11.5 pct at $5.49
** U.S. FDA, on Friday, approved Alimera's eye implant to treat diabetic macular edema, a condition that causes vision impairment due to swelling of the retina
** Company says implant, Iluvien, expected to be available in the United States in early 2015
** Company licensed implant from pSivida Corp in February 2005. pSivida to receive milestone payment of $25 million following approval
** Up to Friday's close, Alimera stock had gained about 5 pct this year
© Thomson Reuters 2017 All rights reserved.